NasdaqCM - Nasdaq Real Time Price USD

Elevai Labs, Inc. (ELAB)

0.6740 +0.0700 (+11.59%)
At close: April 25 at 4:00 PM EDT
0.6591 -0.01 (-2.21%)
After hours: April 25 at 7:22 PM EDT
Loading Chart for ELAB
DELL
  • Previous Close 0.6040
  • Open 0.5800
  • Bid --
  • Ask --
  • Day's Range 0.6000 - 0.7300
  • 52 Week Range 0.5710 - 4.2440
  • Volume 301,032
  • Avg. Volume 676,490
  • Market Cap (intraday) 11.68M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

elevaiskincare.com

18

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ELAB

Performance Overview: ELAB

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ELAB
63.13%
S&P 500
5.84%

1-Year Return

ELAB
--
S&P 500
11.24%

3-Year Return

ELAB
--
S&P 500
11.24%

5-Year Return

ELAB
--
S&P 500
11.24%

Compare To: ELAB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ELAB

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    11.68M

  • Enterprise Value

    8.56M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.23

  • Price/Book (mrq)

    3.05

  • Enterprise Value/Revenue

    5.00

  • Enterprise Value/EBITDA

    -2.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -251.17%

  • Return on Assets (ttm)

    -64.76%

  • Return on Equity (ttm)

    -173.51%

  • Revenue (ttm)

    1.71M

  • Net Income Avi to Common (ttm)

    -4.3M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.33M

  • Total Debt/Equity (mrq)

    5.50%

  • Levered Free Cash Flow (ttm)

    -2.34M

Company Insights: ELAB

Fair Value

0.6740 Current
 

Dividend Score

0 Low
ELAB
Sector Avg.
100 High
 

Hiring Score

0 Low
ELAB
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ELAB
Sector Avg.
100 High
 

People Also Watch